Literature DB >> 9690618

Epidermal growth factor-induced growth inhibition requires Stat1 activation.

J F Bromberg1, Z Fan, C Brown, J Mendelsohn, J E Darnell.   

Abstract

Epidermal growth factor (EGF) is a mitogen for most epithelial cells. Paradoxically, the growth of some cultured cell lines, containing high numbers of EGF receptors, are inhibited by EGF. Here we demonstrate that growth inhibition by EGF in several cell lines correlates with the activation of the signal transducer and activator of transcription (Stat) 1. In contrast, in normal fibroblasts and several cell lines that are growth stimulated by EGF, we observed no or very transient activation of Stat1. A causal association between Stat1 activation by EGF and growth inhibition was suggested by the expression of a dominant-negative Stat1 in A431 cells, resulting in the loss of Stat1 DNA binding and concomitant resistance to growth inhibition by EGF. We conclude that, in the cells examined, EGF-induced arrest of growth requires activated Stat1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690618

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  23 in total

Review 1.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

Authors:  C V Ramana; N Grammatikakis; M Chernov; H Nguyen; K C Goh; B R Williams; G R Stark
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

3.  Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.

Authors:  Ralf Buettner; Renzo Corzano; Rumana Rashid; Jianping Lin; Maheswari Senthil; Michael Hedvat; Anne Schroeder; Allen Mao; Andreas Herrmann; John Yim; Hongzhi Li; Yate-Ching Yuan; Kenichi Yakushijin; Fumiko Yakushijin; Nagarajan Vaidehi; Roger Moore; Gabriel Gugiu; Terry D Lee; Richard Yip; Yuan Chen; Richard Jove; David Horne; John C Williams
Journal:  ACS Chem Biol       Date:  2011-02-16       Impact factor: 5.100

4.  Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells.

Authors:  J S Park; S Carter; D B Reardon; R Schmidt-Ullrich; P Dent; P B Fisher
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

5.  The role of stat1b in zebrafish hematopoiesis.

Authors:  Hao Song; Yi-lin Yan; Tom Titus; Xinjun He; John H Postlethwait
Journal:  Mech Dev       Date:  2011-09-03       Impact factor: 1.882

6.  Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.

Authors:  Julia Kiyan; Roman Kiyan; Hermann Haller; Inna Dumler
Journal:  EMBO J       Date:  2005-05-05       Impact factor: 11.598

Review 7.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

8.  Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways.

Authors:  Junichi Dempoya; Tomoh Matsumiya; Tadaatsu Imaizumi; Ryo Hayakari; Fei Xing; Hidemi Yoshida; Ken Okumura; Kei Satoh
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

9.  The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.

Authors:  Makoto Osaki; Lujian Tan; Bob K Choy; Yasuhiro Yoshida; Kathryn S E Cheah; Philip E Auron; Mary B Goldring
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

10.  Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies.

Authors:  Yan Ren; Piliang Hao; Bamaprasad Dutta; Esther Sok Hwee Cheow; Kae Hwan Sim; Chee Sian Gan; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2012-11-30       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.